These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35115449)
1. Universal Hepatitis B Antibody Screening and Vaccination in Pregnancy: A Cost-Effectiveness Analysis. Prabhu M; Susich MK; Packer CH; Hersch AR; Riley LE; Caughey AB Obstet Gynecol; 2022 Mar; 139(3):357-367. PubMed ID: 35115449 [TBL] [Abstract][Full Text] [Related]
2. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Hung HF; Chen TH Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B: Time to Evaluate Universal Screening and Vaccination in Pregnancy? Badell ML Obstet Gynecol; 2022 Mar; 139(3):355-356. PubMed ID: 35119420 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Chen SC; Toy M; Yeh JM; Wang JD; Resch S Pediatrics; 2013 Apr; 131(4):e1135-43. PubMed ID: 23530168 [TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of universal hepatitis C screening in all United States pregnancies. Susich M; Hersh AR; Greiner K; Chaiken SR; Caughey AB J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7381-7388. PubMed ID: 34392786 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Hutton DW; Tan D; So SK; Brandeau ML Ann Intern Med; 2007 Oct; 147(7):460-9. PubMed ID: 17909207 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the cost-effectiveness of universal hepatitis B virus vaccination in Iran: a Markov model analysis. Mokhtari AM; Barouni M; Moghadami M; Hassanzadeh J; Dewey RS; Mirahmadizadeh A Hum Vaccin Immunother; 2021 Jun; 17(6):1825-1833. PubMed ID: 33734949 [TBL] [Abstract][Full Text] [Related]
8. Strategies for the prevention of perinatal hepatitis B transmission in a marginalized population on the Thailand-Myanmar border: a cost-effectiveness analysis. Devine A; Harvey R; Min AM; Gilder MET; Paw MK; Kang J; Watts I; Hanboonkunupakarn B; Nosten F; McGready R BMC Infect Dis; 2017 Aug; 17(1):552. PubMed ID: 28793866 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China. Jia Y; Li L; Cui F; Zhang D; Zhang G; Wang F; Gong X; Zheng H; Wu Z; Miao N; Sun X; Zhang L; Lv J; Yang F Hum Vaccin Immunother; 2014; 10(10):2983-91. PubMed ID: 25483678 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus--the case of Belgium. Tormans G; Van Damme P; Carrin G; Clara R; Eylenbosch W Soc Sci Med; 1993 Jul; 37(2):173-81. PubMed ID: 8351532 [TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections. Hutton DW; Toy M; Salomon JA; Conners EE; Nelson NP; Harris AM; So S Sex Transm Dis; 2022 Jul; 49(7):517-525. PubMed ID: 35312661 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. Arevalo JA; Washington AE JAMA; 1988 Jan; 259(3):365-9. PubMed ID: 2961895 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. Rossi C; Schwartzman K; Oxlade O; Klein MB; Greenaway C PLoS One; 2013; 8(10):e78548. PubMed ID: 24205255 [TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness. Vimolket T; Poovorawan Y Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440 [TBL] [Abstract][Full Text] [Related]
15. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness. Harris A; Yong K; Kermode M Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989 [TBL] [Abstract][Full Text] [Related]
16. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis. Krahn M; Detsky AS Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine. Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation. Su S; Wong WC; Zou Z; Cheng DD; Ong JJ; Chan P; Ji F; Yuen MF; Zhuang G; Seto WK; Zhang L Lancet Glob Health; 2022 Feb; 10(2):e278-e287. PubMed ID: 35063115 [TBL] [Abstract][Full Text] [Related]
19. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis. Plunkett BA; Grobman WA Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195 [TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of universal newborn hepatitis B vaccination in China. Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]